JP2024505212A5 - - Google Patents
Info
- Publication number
- JP2024505212A5 JP2024505212A5 JP2023545813A JP2023545813A JP2024505212A5 JP 2024505212 A5 JP2024505212 A5 JP 2024505212A5 JP 2023545813 A JP2023545813 A JP 2023545813A JP 2023545813 A JP2023545813 A JP 2023545813A JP 2024505212 A5 JP2024505212 A5 JP 2024505212A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- cbd
- sleep
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163142835P | 2021-01-28 | 2021-01-28 | |
| US63/142,835 | 2021-01-28 | ||
| PCT/IB2022/050781 WO2022162621A1 (en) | 2021-01-28 | 2022-01-28 | Treatment of sleep apnea with cbd |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024505212A JP2024505212A (ja) | 2024-02-05 |
| JP2024505212A5 true JP2024505212A5 (cg-RX-API-DMAC7.html) | 2025-01-28 |
Family
ID=80222209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023545813A Pending JP2024505212A (ja) | 2021-01-28 | 2022-01-28 | Cbdを用いた睡眠時無呼吸の処置 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240307418A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4284349A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024505212A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230137404A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116829135A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022213009A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3206508A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL304827A (cg-RX-API-DMAC7.html) |
| JO (1) | JOP20230169A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023008876A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022162621A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20260207632A1 (en) * | 2022-12-16 | 2026-07-23 | Kingdom Therapeutics Limited | Cannabinoid based therapy |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8449908B2 (en) | 2000-12-22 | 2013-05-28 | Alltranz, Llc | Transdermal delivery of cannabidiol |
| WO2010127033A1 (en) | 2009-04-28 | 2010-11-04 | Alltranz Inc. | Formulations of cannabidiol and methods of using the same |
| CA3065563C (en) * | 2017-06-19 | 2023-06-13 | Zelda Therapeutics Operations Pty Ltd | Sleep disorder compositions and treatments thereof |
| GB2572737A (en) * | 2018-01-24 | 2019-10-16 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| CA3099980A1 (en) * | 2018-05-11 | 2019-11-14 | Rhodes Technologies Inc. | Compositions and dosage forms for oral delivery |
| WO2019224824A1 (en) * | 2018-05-24 | 2019-11-28 | To Pharmaceuticals Llc | Cannabis-based compositions for the treatment of autistic spectrum disorders |
| EP3753555A1 (en) * | 2019-06-19 | 2020-12-23 | Universität Basel | Composition for inhalation comprising cannabidiol for the treatment of mental disorder and/or drug addiction and/or sleep disorder and/or pain |
| WO2021055499A1 (en) * | 2019-09-17 | 2021-03-25 | Zynerba Pharmaceuticals, Inc. | Treatment of behavioral impairment in developmental and epileptic encephalopathy |
-
2022
- 2022-01-28 US US18/263,092 patent/US20240307418A1/en not_active Abandoned
- 2022-01-28 AU AU2022213009A patent/AU2022213009A1/en active Pending
- 2022-01-28 CN CN202280012395.XA patent/CN116829135A/zh active Pending
- 2022-01-28 JP JP2023545813A patent/JP2024505212A/ja active Pending
- 2022-01-28 CA CA3206508A patent/CA3206508A1/en active Pending
- 2022-01-28 WO PCT/IB2022/050781 patent/WO2022162621A1/en not_active Ceased
- 2022-01-28 EP EP22703076.4A patent/EP4284349A1/en active Pending
- 2022-01-28 KR KR1020237029079A patent/KR20230137404A/ko active Pending
- 2022-01-28 MX MX2023008876A patent/MX2023008876A/es unknown
-
2023
- 2023-07-27 JO JOJO/P/2023/0169A patent/JOP20230169A1/ar unknown
- 2023-07-30 IL IL304827A patent/IL304827A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Clark et al. | Sleep apnea: treatment with protriptyline | |
| Andrade et al. | The role of physical exercise in obstructive sleep apnea | |
| Schütz et al. | New frontiers in pharmacologic obstructive sleep apnea treatment: a narrative review | |
| Manji et al. | Status dystonicus: the syndrome and its management. | |
| AU684087B2 (en) | Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin | |
| Stepnowsky Jr et al. | Nasal CPAP treatment for obstructive sleep apnea: developing a new perspective on dosing strategies and compliance | |
| RU2010121827A (ru) | Композиции для лечения болезни паркинсона | |
| JP2025084754A (ja) | 睡眠時無呼吸を治療するための方法および組成物 | |
| JP4896334B2 (ja) | 睡眠時呼吸障害を治療及び診断する方法並びにその方法を実施する手段 | |
| KR101187461B1 (ko) | 각성을 향상시키는 방법 | |
| Wojda et al. | Mandibular advancement devices in obstructive sleep apnea patients intolerant to continuous positive airway pressure treatment | |
| US5502067A (en) | Treating apneahypopnea/snoring in humans | |
| Aishah et al. | P001 Safety, tolerability, and efficacy of 1 month of atomoxetine plus oxybutynin in obstructive sleep apnoea | |
| JP2023539847A5 (cg-RX-API-DMAC7.html) | ||
| US20240139200A1 (en) | Combination of reboxetine and a muscarinic receptor antagonist (mra) for use in treating sleep apnea | |
| CN116712420B (zh) | 一种花椒酰胺在制备治疗多发性硬化症的药物中的应用 | |
| Aishah et al. | P002 Targeted non-CPAP combination therapy resolves obstructive sleep apnoea | |
| CN115154448B (zh) | 一种治疗不宁腿综合征的药物及其制备方法和应用 | |
| Ekselius et al. | P. 1.040 A double-blind study comparing sertraline and citalopram in patients with major depression treated in general practice | |
| Wojda et al. | in Obstructive Sleep Apnea Patients Intolerant to Continuous Positive Airway | |
| CN107412234A (zh) | 一叶萩碱的药物用途 | |
| Amaranayake et al. | P003 The impact of forced wake from overnight polysomnography on multiple sleep latency test results | |
| Hu et al. | Low dose esketamine for gastrointestinal endoscopy: a double-blinded, randomized controlled trial. | |
| Lockhart | (834): Topical sterile lidocaine patch to reduce postoperative pain and decrease need for oral analgesics after inguinal herniorrhaphy | |
| TW202310855A (zh) | 使用一氧化二氮或任何吸入性麻醉劑治療covid-19及其他病毒感染、細菌感染、損傷、急性呼吸窘迫症候群或導致p物質水平急性升高引起細胞激素系統之病理性活化之病症 |